Marco Proietti
Marco Proietti
Department of Clinical Sciences and Community Health, University of Milan
Verified email at unimi.it
TitleCited byYear
Platelet activation is associated with myocardial infarction in patients with pneumonia
R Cangemi, M Casciaro, E Rossi, C Calvieri, T Bucci, CM Calabrese, ...
Journal of the American College of Cardiology 64 (18), 1917-1925, 2014
942014
Adherence to oral anticoagulant therapy in patients with atrial fibrillation
V Raparelli, M Proietti, R Cangemi, GYH Lip, DA Lane, S Basili
Thrombosis and haemostasis 117 (02), 209-218, 2017
842017
Evaluation of the HAS-BLED, ATRIA, and ORBIT bleeding risk scores in patients with atrial fibrillation taking warfarin
K Senoo, M Proietti, DA Lane, GYH Lip
The American journal of medicine 129 (6), 600-607, 2016
812016
Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age/gender differences and cardiovascular outcomes
Q Xiong, M Proietti, K Senoo, GYH Lip
International journal of cardiology 191, 172-177, 2015
702015
Atrial fibrillation and thromboembolism in patients with chronic kidney disease
YC Lau, M Proietti, E Guiducci, AD Blann, GYH Lip
Journal of the American College of Cardiology 68 (13), 1452-1464, 2016
532016
Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2 score
M Proietti, GYH Lip
European Heart Journal-Cardiovascular Pharmacotherapy 1 (3), 150-152, 2015
472015
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy
F Violi, G DavÝ, W Hiatt, GYH Lip, GR Corazza, F Perticone, M Proietti, ...
Journal of the American College of Cardiology 62 (23), 2255-2256, 2013
442013
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study
M Proietti, A Nobili, V Raparelli, L Napoleone, PM Mannucci, GYH Lip
Clinical Research in Cardiology 105 (11), 912-920, 2016
402016
Major bleeding in patients with non-valvular atrial fibrillation: impact of time in therapeutic range on contemporary bleeding risk scores
M Proietti, K Senoo, DA Lane, GYH Lip
Scientific reports 6, 24376, 2016
402016
a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Circulation 135 (10), e146-e603, 2017
39*2017
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
M Proietti, V Raparelli, B Olshansky, GYH Lip
Clinical Research in Cardiology 105 (5), 412-420, 2016
372016
A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme
M Proietti, GH Mairesse, P Goethals, C Scavee, J Vijgen, I Blankoff, ...
Ep Europace 18 (12), 1779-1786, 2016
352016
Platelet isoprostane overproduction in diabetic patients treated with aspirin
R Cangemi, P Pignatelli, R Carnevale, C Nigro, M Proietti, F Angelico, ...
Diabetes 61 (6), 1626-1632, 2012
342012
Real-world use of apixaban for stroke prevention in atrial fibrillation: a systematic review and meta-analysis
M Proietti, I Romanazzi, GF Romiti, A Farcomeni, GYH Lip
Stroke 49 (1), 98-106, 2018
332018
Elderly obese women display the greatest improvement in stair climbing performance after a 3-week body mass reduction program
A Sartorio, CL Lafortuna, F Agosti, M Proietti, NA Maffiuletti
International journal of obesity 28 (9), 1097, 2004
322004
‘Real-world’atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registryá…
M Proietti, C Laroche, G Opolski, AP Maggioni, G Boriani, GYH Lip, ...
Europace 19 (5), 722-733, 2016
302016
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillationá…
G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ...
Ep Europace 20 (5), 747-757, 2017
292017
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non–Vitamin K Antagonist Oral Anticoagulant Trials
M Proietti, E Guiducci, P Cheli, GYH Lip
Stroke 48 (4), 857-866, 2017
292017
VEGF-A gene promoter polymorphisms and microvascular complications in patients with essential hypertension
R Palmirotta, P Ferroni, G Ludovici, F Martini, A Savonarola, ...
Clinical biochemistry 43 (13-14), 1090-1095, 2010
292010
Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation
M Proietti, AM Marra, EJ Tassone, S De Vuono, S Corrao, P Gobbi, ...
The American journal of cardiology 116 (6), 877-882, 2015
282015
The system can't perform the operation now. Try again later.
Articles 1–20